CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Sector revisions Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 205.52 USD | +0.88% |
|
+8.98% | -12.40% |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 17 | |||||||||
| 21 | |||||||||
| 21 | |||||||||
| 27 | |||||||||
| 19 | |||||||||
| 19 | |||||||||
| 15 | |||||||||
| 13 | |||||||||
| 13 | |||||||||
| 9 | |||||||||
| 17 | |||||||||
| - | - | - | 8 | ||||||
| 14 | |||||||||
| 6 | |||||||||
| 25 | |||||||||
| 16 | |||||||||
| 17 | |||||||||
| 12 | |||||||||
| 13 | |||||||||
| Average | 16 | ||||||||
| Weighted average by Cap. | 18 |
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition